R Michael Carruthers
CIK 1644467 · Chief Financial Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.02M
Companies
5
Total Filings
27
Lifetime Open-Market Net
-$5.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OKUR | Director | 4,939 | $4.20 | $20.7K | $0 | 3 | 2026-06-08 |
| EWTX | Chief Financial Officer | 86,162 | $34.83 | $3.00M | -$5.09M | 14 | 2025-08-14 |
| Elevation Oncology, Inc. (ELEV) Delisted | Director | — | $0.36 | — | $0 | 5 | 2025-07-24 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Chief Financial Officer | — | $2.35 | — | $0 | 1 | 2020-03-18 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Interim President / CFO | 24,000 | — | — | $50.3K | 4 | 2017-01-23 |
Recent Filings · Page 3 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-03 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2021-08-19 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2020-03-18 | Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-23 | ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-05 | ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Buy (P) | +24,000 | $50.3K | EDGAR |
| 2016-09-14 | ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-15 | ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–27 of 27
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.